Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideaki Miyake

Showing results (21-30 of 587) with videos related to

Pageof 59
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 28, 2016
[Robot-assisted radical prostatectomy]Hideaki Miyake, Masato Fujisawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 15, 2018
Drug therapy for renal cell carcinoma in the elderlyHideaki Miyake, Seiichiro Ozono
World Journal of Urology|March 17, 2005
Use of antisense oligonucleotides targeting the cytoprotective gene, clusterin, to enhance androgen- and chemo-sensitivity in prostate cancerMartin Gleave, Hideaki Miyake
Expert Review of Anticancer Therapy|December 3, 2008
Promise of antisense oligodeoxynucleotide-based therapy for bladder cancerHideaki Miyake, Masato Fujisawa
Hinyokika Kiyo. Acta Urologica Japonica|May 19, 2011
[Salvage chemotherapy for patients with germ cell cancer]Hideaki Miyake, Masato Fujisawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 16, 2011
[Tuberculosis in urogenital organs]Hideaki Miyake, Masato Fujisawa
International Journal of Urology : Official Journal of the Japanese Urological Association|November 26, 2014
Editorial comment to Salvage combined chemotherapy with paclitaxel, ifosfamide and nedaplatin for patients with advanced germ cell tumorsHideaki Miyake, Masato Fujisawa
International Journal of Urology : Official Journal of the Japanese Urological Association|October 2, 2012
Prognostic prediction following radical prostatectomy for prostate cancer using conventional as well as molecular biological approachesHideaki Miyake, Masato Fujisawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 3, 2012
[Antisense oligonucleotide therapy for patients with castration-resistant prostate cancer]Mototsugu Muramaki, Hideaki Miyake, Masato Fujisawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 3, 2012
[The efficacy of PSA related parameters]Tomoaki Terakawa, Hideaki Miyake, Masato Fujisawa
Pageof 59

Showing results (21-30 of 587) with videos related to

Sort By:
Pageof 59
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 28, 2016
[Robot-assisted radical prostatectomy]Hideaki Miyake, Masato Fujisawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 15, 2018
Drug therapy for renal cell carcinoma in the elderlyHideaki Miyake, Seiichiro Ozono
World Journal of Urology|March 17, 2005
Use of antisense oligonucleotides targeting the cytoprotective gene, clusterin, to enhance androgen- and chemo-sensitivity in prostate cancerMartin Gleave, Hideaki Miyake
Expert Review of Anticancer Therapy|December 3, 2008
Promise of antisense oligodeoxynucleotide-based therapy for bladder cancerHideaki Miyake, Masato Fujisawa
Hinyokika Kiyo. Acta Urologica Japonica|May 19, 2011
[Salvage chemotherapy for patients with germ cell cancer]Hideaki Miyake, Masato Fujisawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 16, 2011
[Tuberculosis in urogenital organs]Hideaki Miyake, Masato Fujisawa
International Journal of Urology : Official Journal of the Japanese Urological Association|November 26, 2014
Editorial comment to Salvage combined chemotherapy with paclitaxel, ifosfamide and nedaplatin for patients with advanced germ cell tumorsHideaki Miyake, Masato Fujisawa
International Journal of Urology : Official Journal of the Japanese Urological Association|October 2, 2012
Prognostic prediction following radical prostatectomy for prostate cancer using conventional as well as molecular biological approachesHideaki Miyake, Masato Fujisawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 3, 2012
[Antisense oligonucleotide therapy for patients with castration-resistant prostate cancer]Mototsugu Muramaki, Hideaki Miyake, Masato Fujisawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 3, 2012
[The efficacy of PSA related parameters]Tomoaki Terakawa, Hideaki Miyake, Masato Fujisawa
Pageof 59